News

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.
The Government has announced a pilot to test new ways to support patients living with obesity, in a bid to ease pressures on ...
When Eli Lilly (LLY) posted strong quarterly results, the stock fell from $750 to $625.65 by August 8. Shareholders fretted about clinical results from its next-generation obesity drug. Its 37.7% Y/Y ...
FAT jabs could be made available over the ­counter at pharmacies without the need for a GP to get involved. It is one idea ...
The Government has joined forces with the pharmaceutical giant that makes weight loss jab Mounjaro in a bid to tackle obesity ...
"Tirzepatide and other drugs like it, such as semaglutide, will help people living with obesity to lose weight, and as a ...
The mother's eyes turned yellow among other side effects while on Mounjaro, which had a devastating effect on her gallbladder ...
A wide variety of unapproved FDA drugs were discovered during inspections, including nearly 55,000 fake injectables and pills ...
Eli Lilly and Company (NYSE: LLY) is one of the top most profitable NYSE stocks to buy now. On August 7, Leerink downgraded ...
The program will offer pathways into genetic engineering, personalized medicine, cell and gene therapy, soil and water remediation and sustainable agriculture.
A mum who admitted that she has illegally put her 13-year-old child on Mounjaro weight loss jabs has spoken out on why she ...
A legacy ranch in Jackson Hole, WY, has come onto the market, with records showing it is owned by former Eli Lilly exec Dr.